Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, January 11, 2024
PCM Trials, a Denver, USA-based provider of mobile research nurses for decentralized clinical trials (DCTs), announced the acquisition of Clinical Trial Service (CTS).
read more
Global pharmaceutical outsourcing services provider PCI Pharma Services (PCI) is pleased to announce a laboratory expansion at its site in Tredegar, Wales, UK.
read more
Monday, September 17, 2018
PCI Pharma Services announced its exclusive collaboration agreement with CSP Technologies for U.S. clinical trials and stability testing utilizing Activ-Blister packaging solutions.
read more
PCI Synthesis announced the company’s president, Ed Price, has joined the Board of Governors of the Society of Chemical Manufacturers and Affiliates (SOCMA).
read more
Wednesday, December 26, 2018
Novacap announced that it will combine its Contract Development and Manufacturing Organization subsidiaries – PCI Synthesis, PCAS, Uetikon and Proteus – into a new entity to be known as SEQENS.
read more
Wednesday, April 20, 2016
PCI Synthesis, Inc. has announced the formation of its cGMP Advanced Polymer Development and Manufacturing Group, which is currently developing and manufacturing more than a dozen advanced polymer-based projects.
read more
PCI Pharma Services has announced a footprint expansion program at its site in Tredegar, South Wales. This latest expansion demonstrates continued investment in PCI Pharma Services’ Tredegar facility.
read more
Wednesday, August 21, 2024
PCI Pharma Services has successfully completed the International Coalition of Medicines Regulatory Authorities (ICMRA) inspection of its Bedford, New Hampshire campus.
read more
PCI and Experic are with a strategic, synergistic partnership involving clinical and commercial manufacturing, packaging and supply chain services.
read more
PCI Pharma Services is acquiring an entire equity stake in Ajinomoto Althea, Inc., a US-based sterile fill-finish CDMO and 100% subsidiary of Japan-based Ajinomoto Co., Inc.
read more
PCI Pharma Services has released its first Environmental, Social & Governance (ESG) Report. A detailed overview of PCI's multifaceted sustainability journey, the report showcases the strides taken from the program's formal inception in 2021 through ...
read more
PCI Pharma Services announced that it received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg and supported with significant reinvestment by Mubadala Investment Company. Partners Group will also continue to support ...
read more
Monday, September 30, 2024
PCI Pharma Services announced it is investing more than $365M in infrastructure supporting the clinical and commercial-scale final assembly and packaging of drug-device combination products utilizing advanced drug delivery systems, with an emphasis ...
read more
Thursday, February 03, 2022
PCI Pharma Services (PCI) announced the addition of three new automated sterile fill-finish machines in its San Diego and Melbourne facilities. Purchased from Cytiva, this equipment can pivot between filling different sterile medications into vials ...
read more
Wednesday, December 04, 2019
PCI Pharma Services announced the completion of an expansion to its Rockford, IL facility to enhance its Specialty Drug Product Capabilities.
read more